CEO, Board Member, President, VP Sales, VP Marketing, Commercial Roles

Sean is a seasoned leader in the medical device space with significant commercialization expertise in launching new and novel technologies. As co-founder of 360 Life Sciences Advisors, Sean has a passion for defining vision while positioning entrepreneurial, early-stage, and midsize U.S./global businesses for record performance.

As CEO of Origami Surgical, Sean built the infrastructure of this startup company from A-Round to full commercialization. He expanded the portfolio from one to ten products, including five FDA clearances. He expanded the IP portfolio to protect the technology for future development.

Prior to this, Sean was the U.S. President for the Sorin Group (now LivaNova), a medical technology company specializing in cardiac devices for surgery. In this role, he held General Manager level, P&L accountability for the U.S. Perfusion and Heart Valve businesses.

Sean served as U.S. Vice President of Sales & Marketing at Covidien (now Medtronic), where he held full P&L responsibility for three divisions with combined $350M annual revenue.

He was VP of Sales for a start-up, OmniSonics Medical Technologies, to establish the sales organization, develop product commercialization efforts, and initiate centers for limited post-FDA-approval market release. Prior to that, Sean was at DataScope (now Maquet), where he was VP Sales for both the Vascular Division as well as the Interventional Products Division.

The trajectory of Sean’s career began when he joined U.S. Surgical as a Sales Representative. He held positions of increasing scope and responsibility in both sales and marketing. He gained solid experience launching and selling disposable, implantable and capital equipment across a wide range of surgical specialties.

Sean serves as an Entrepreneur in Residence for Yale Ventures as well as an advisor to Cleveland Clinic Innovations & Ventures.